Alcohol abuse leads to impotence, infertility, and feminisation. Patients with chronic alcoholism may have impaired hypothalamic-pituitary function. The release of luteinising hormone was investigated in men with alcoholic cirrhosis with and without hypogonadism and controls. Blood was sampled every 15 minutes for six or eight hours and luteinising hormone concentrations measured by radioimmunoassay. Data were analysed by iterative computerised analysis and spectral analysis to assess pulsatile release and the length of the cycle, respectively. Pulsatile release of luteinising hormone was shown in all the control subjects; in the men with alcoholic liver disease it was normal in those with subclinical primary testicular failure but absent or grossly attenuated in those with overt combined central and primary gonadal failure.
Introduction
Alcoholic liver disease may lead to impotence, infertility, and feminisation in men and amenorrhoea in women.' 2 Ethanol has a direct toxic effect on the gonads, causing impaired spermatogenesis and abnormal morphology of Leydig's cells,3 but data on hypothalamic-pituitary function in alcoholic liver disease are conflicting. Basal plasma luteinising hormone concentrations are normal, but response to clomiphene is attenuated and testosterone concentrations are low.4' The release of luteinising hormone is pulsatile,6 and a contributory factor to the above findings may be impaired release of the hormone. The present study was designed to test this hypothesis.
Subjects and methods
We studied two groups of patients. One comprised four men (aged 32-53) with chronic alcoholic liver disease and no clinical signs of gonadal failure, and the other comprised five men (aged 38-62) with alcoholic liver disease and clinical signs of hypogonadism. All patients had histologically proved cirrhosis of the liver. The presence or absence ofhypogonadism was assessed clinically. Testicular atrophy (testicular volume less than 10 ml), loss of pubic and axillary hair, and a reduced frequency of shaving were noted in all five men with overt hypogonadism. All nine patients had stable liver disease and had not changed their drug treatment in the three weeks before the study day. Table I gives details of the patients. Hepatomegaly was assessed on a three point scale: + =less than 5 cm below the costal margin, + + = 5-10 cm below the costal margin, +++=more than 10 cm below the costal margin. Healthy male controls recruited from a volunteer population and matched for age (to within three years) and duration of sampling (six or eight hours) were also studied.
RADIOIMMUNOASSAY
Luteinising hormone was measured by a double antibody radioimmunoassay using macrogol assisted double antibody precipitation. Concentrations of luteinising hormone were expressed in IU/1 in terms of MRC standard 68/40. The mean intra assay coefficient of variation of the usable portions of the standard curve was 3 1% and the mean inter assay coefficient of variation 3l1%.
Androgens-The androgens testosterone, androstenedione, and dehydroepiandrosterone sulphate were measured with a single antibody radioimmunoassay. The plasma steroids were extracted from an appropriate dilution of serum with ether. The ether was dried down and the residue resuspended in buffer. All steroids were measured in the aqueous phase using ligands labelled with tritium. The specificity of the antisera and inter assay and intra assay coefficients ofvariation have been reported previously.7
STATISTICAL ANALYSIS
Data from each group were compared for significant differences by the Mann-Whitney U test. Two methods were used to analyse the data for appreciable pulses of luteinising hormone.
Iterative pulse analysis-Discrete pulses were detected with a computer, using an iterative process to distinguish the pulses of maximum amplitude.' This method is a variation on the threshold technique. Pulses are deemed appreciable if they exceed the threshold by a predetermined amount (usually related to the coefficient of variation of the assay). The method can be used to analyse both irregular and regular rhythms. It has the advantage over simple visual analysis of data that observer bias is removed, and it allows pulses to be detected when background noise is fairly high. In the program used the threshold was adjusted for each set of data, thus improving the detection of pulses against background noise. The analysis provided an estimate of the ratio of signal to noise; it is recommended that data should not be analysed if this ratio is less than 4:1 in experiments containing 18-35 samples. Spectral analysis-A disadvantage of threshold techniques is that patterns of secretion of hormones with a long cycle-for example, diurnal vari-BRITISH MEDICAL JOURNAL VOLUME 293 8 NOVEMBER 1986 ation are not detected. Spectral analysis, also called time series analysis, is a mathematical method for estimating the patterns or harmonics of wave forms, which if summed would reproduce the original data. It can detect both fast and slow wave forms, though it is more useful for detecting slow wave forms. This method of analysis permits measurement of release of hormones that is non-pulsatile and of low frequency. The method of Murdoch et al was used. 9 The results of the analysis were expressed as a periodogram, which portrayed all the data collected, both appreciable harmonics (or patterns of release) and the background noise. An assessment of the significance of the data was included in the computer program. Briefly, this was a 95% one sided tolerance limit that was added to the periodogram; any harmonics above the tolerance limit were significant at a probability of 0-05.9 This allowed the significance of the detected harmonics above the background noise to be assessed (fig 1) . Overt gonadal'ailuret (table II) All nine patients had the pattern of androgen disturbance reported previously for similar groups of patients'" "-namely, low testosterone, low dehydroepiandrosterone sulphate, and raised androstenedione concentrations.
LUTEINISING HORMONE CONCENTRATION
The mean concentration of luteinising hormone was higher in the patients with subclinical primary testicular failure than in their controls (10-6 v 5-6 IU/1; p<005). The mean concentration did not differ significantly between the patients with overt hypogonadism and their controls (5 5 v 6-4 IU/1).
PULSE ANALYSIS (table III) Iterative analysis-The ratio of signal to noise exceeded 5:1 in all cases. Appreciable pulses of luteinising hormone were identified in all the patients with subclinical primary testicular failure and their matched controls. No significant difference was seen in the number ofpulses. The amplitude ofthe pulses tended to be increased in the patients, but this trend did not reach significance (figs 2 and 3) . In contrast the release of luteinising hormone in the patients with overt hypogonadism was attenuated. A single pulse was seen in three patients, and no pulses were seen in two (patients v controls p<001; fig 4) . Spectal analysis-All four patients with subclinical primary testicular failure and their controls showed release of luteinising hormone with a frequency of 240 minutes. One patient also showed release with a frequency of 120 minutes. None ofthe five men with overt hypogonadism showed a low frequency release of luteinising hormone.
Discussion
Our study showed two patterns of release of luteinising hormone in men with chronic alcoholic liver disease. In those men with no clinical signs of hypogonadism (cases 14) pulsatility of luteinising hormone was preserved and mean concentrations of the hormone were increased. This is the pattern of release seen in primary testicular failure and may reflect a normal response of luteinising hormone to the reduced testosterone concentrations.'2 In the men with overt gonadal failure (cases 5-9) the release of luteinising hormone was severely attenuated and mean concentrations of the hormone were not raised. This is the pattern seen in hypogonadism of "hypothalamic origin"-for example, secondary to hyperprolactinaemia. 6 In this second group androgen concentrations did not differ significantly from those in the group with subclinical primary testicular failure, and thus the impaired release ofluteinising hormone is presumptive evidence for impaired hypothalamic control. Spectral analysis showed the release of luteinising hormone in healthy controls to have a cycle of 240 minutes; this pattern of release was-preserved in the men with alcoholic liver disease without hypogonadism. In the group with overt gonadal failure this pattern of release was-lost, providing further enidence for a hypothalamic defect.
From the present data we cannot implicate liver disease per se in the reduction of pulsatility of luteinising hormone. Abnormal pulsatility of the hormone (as determined by radioimmunoassay) has recently been shown in other chronic diseases such as chronic renal failure,'3 though, interestingly, in renal disease the function of bioactive luteinising hormone seems to be preserved. In healthy menacutealcohol consumption does not significantlyalterpulsatility of luteinising hormone,'4 but daily consumption may have a different effect in those destined to become alcoholic.
